Contact
searchSearch
HMP Global

SIO Corner

The Society of Interventional Oncology (SIO) is a non-profit association that supports and promotes the field of interventional oncology (IO). SIO members are invited to submit research highlights, clinical images, and reviews on IO-related topics. Submissions may be directed to our SIO Corner Section Editor, Elena Violari, at eviolari@live.com.

Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
Addition of Durvalumab, Bevacizumab to TACE for Hepatocellular Carcinoma Improves PFS
01/23/2024
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology
Dr. Kavi Krishnasamy and Dr. Vijay Ramalingam
Podcast
SIO 2024 Preview: A Conversation With Conference Chair Vijay Ramalingam
01/03/2024
In this episode of the IOL Radio Podcast, Kavi Krishnasamy, MD, interventional radiologist at Columbia University Irving Medical Center, and his guest Vijay Ramalingam, MD, IR professional at Beth Israel Deaconess Medical Center, discuss the...
In this episode of the IOL Radio Podcast, Kavi Krishnasamy, MD, interventional radiologist at Columbia University Irving Medical Center, and his guest Vijay Ramalingam, MD, IR professional at Beth Israel Deaconess Medical Center, discuss the...
In this episode of the IOL Radio...
01/03/2024
IO Learning
Dr. AJ Gun, Dr. Christopher Malone
Podcast
Award-Winning Abstract From SIO 2023
06/30/2023
Dr Gunn and Dr Malone discuss Dr. Malone’s Award-Winning abstract from SIO 2023, the process of actualizing this study, and what to expect from Dr. Malone and his colleagues at SIO 2024.
Dr Gunn and Dr Malone discuss Dr. Malone’s Award-Winning abstract from SIO 2023, the process of actualizing this study, and what to expect from Dr. Malone and his colleagues at SIO 2024.
Dr Gunn and Dr Malone discuss...
06/30/2023
IO Learning
Dr Elena Violari and Dr Erica Alexander
Podcast
The SIO's Resident Medical Student Section Launch
06/20/2023
Dr Violari and Dr Alexander discuss the launching of the SIO resident medical student section, a new opportunity developed by SIO for medical students to connect and collaborate.
Dr Violari and Dr Alexander discuss the launching of the SIO resident medical student section, a new opportunity developed by SIO for medical students to connect and collaborate.
Dr Violari and Dr Alexander...
06/20/2023
IO Learning
Lynn Savic, MD, PhD, and AJ Gunn, MD
Podcast
The SIO’s Talk Tuesday Educational Lecture Series
05/11/2023
Dr AJ Gunn and Dr Lynn Savic discuss the SIO’s Talk Tuesdays initiative, a virtual series that includes free educational lectures designed for trainees and early-career interventional radiologists.
Dr AJ Gunn and Dr Lynn Savic discuss the SIO’s Talk Tuesdays initiative, a virtual series that includes free educational lectures designed for trainees and early-career interventional radiologists.
Dr AJ Gunn and Dr Lynn Savic...
05/11/2023
IO Learning
Dr Elena Violari and Dr Constantinos Sofocleous
Podcast
The ACCLAIM Trial to Assess Microwave Ablation as the Standard of Care for Colorectal Liver Metastases
03/07/2023
ACCLAIM, the first international trial launched by the SIO, assesses microwave ablation as the standard of care for colorectal liver mets. Study PI Constantinos Sofocleous provides an update on ACCLAIM, which recently enrolled its first...
ACCLAIM, the first international trial launched by the SIO, assesses microwave ablation as the standard of care for colorectal liver mets. Study PI Constantinos Sofocleous provides an update on ACCLAIM, which recently enrolled its first...
ACCLAIM, the first international...
03/07/2023
IO Learning
Violari and Bryce
Podcast
Percutaneous Locoregional Therapies for the Treatment of Breast Cancer
01/21/2023
Dr Elena Violari and Dr Yolanda Bryce discuss percutaneous locoregional therapies for the treatment of breast cancer.
Dr Elena Violari and Dr Yolanda Bryce discuss percutaneous locoregional therapies for the treatment of breast cancer.
Dr Elena Violari and Dr Yolanda...
01/21/2023
IO Learning
Dr Alan Sag
SIO2023 Highlights
Current Trends and Future Directions in Musculoskeletal Interventions
01/20/2023
Alan Alper Sag, MD, Assistant Professor, Duke Interventional Radiology and Duke Orthopaedic Surgery, discusses the current state and future of musculoskeletal interventions.
Alan Alper Sag, MD, Assistant Professor, Duke Interventional Radiology and Duke Orthopaedic Surgery, discusses the current state and future of musculoskeletal interventions.
Alan Alper Sag, MD, Assistant...
01/20/2023
IO Learning
Violari and Gandhi
Podcast
The Latest Advancements in Y-90 Radioembolization and Practical Tips for Building a Y-90 Program
12/13/2022
In the latest offering from the SIO Corner, Dr Ripal Gandhi discusses his experiences building a successful Y-90 program along with recent advancements in Y-90 radioembolization.
In the latest offering from the SIO Corner, Dr Ripal Gandhi discusses his experiences building a successful Y-90 program along with recent advancements in Y-90 radioembolization.
In the latest offering from the...
12/13/2022
IO Learning
Dupuy and Ramalingam
Podcast
SIO2023 Preview: A Conversation With Conference Chairs Damian Dupuy and Vijay Ramalingam
11/07/2022
Damian Dupuy, MD, Program Chair, and Vijay Ramalingam, MD, Scientific Chair, share highlights of the upcoming Annual Scientific Meeting of the Society of Interventional Oncology.
Damian Dupuy, MD, Program Chair, and Vijay Ramalingam, MD, Scientific Chair, share highlights of the upcoming Annual Scientific Meeting of the Society of Interventional Oncology.
Damian Dupuy, MD, Program Chair,...
11/07/2022
IO Learning
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
Addition of Durvalumab, Bevacizumab to TACE for Hepatocellular Carcinoma Improves PFS
01/23/2024
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology
Dr. Kavi Krishnasamy and Dr. Vijay Ramalingam
Podcast
SIO 2024 Preview: A Conversation With Conference Chair Vijay Ramalingam
01/03/2024
In this episode of the IOL Radio Podcast, Kavi Krishnasamy, MD, interventional radiologist at Columbia University Irving Medical Center, and his guest Vijay Ramalingam, MD, IR professional at Beth Israel Deaconess Medical Center, discuss the...
In this episode of the IOL Radio Podcast, Kavi Krishnasamy, MD, interventional radiologist at Columbia University Irving Medical Center, and his guest Vijay Ramalingam, MD, IR professional at Beth Israel Deaconess Medical Center, discuss the...
In this episode of the IOL Radio...
01/03/2024
IO Learning
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
Interview
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
12/08/2023
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview,...
12/08/2023
IO Learning
Dr. Riad Salem
Interview
Redefining the ‘Status Quo’ of IO
12/07/2023
In this interview with Riad Salem, MD, Chief of Vascular and Interventional Radiology in the Department of Radiology at Northwestern Medicine, we discuss the future of IO, unique approaches to Y-90, and what's next for the interventional...
In this interview with Riad Salem, MD, Chief of Vascular and Interventional Radiology in the Department of Radiology at Northwestern Medicine, we discuss the future of IO, unique approaches to Y-90, and what's next for the interventional...
In this interview with Riad...
12/07/2023
IO Learning
Dr. Edward Kim
CIO2023 Highlights
HCC, Flow-Diversion, and IO Outpatient Labs with Dr. Edward Kim
12/06/2023
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr....
12/06/2023
IO Learning
Dr. AJ Gunn Unmasked
Interview
IO ‘Unmasked’: An Interview With Dr. AJ Gunn
11/07/2023
In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.
In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.
In this interview, Dr. AJ Gunn...
11/07/2023
IO Learning
Dr. Raul Uppot
Video
Key Points of HCC With Dr. Raul Uppot
10/26/2023
In this brief highlight from IO Learning’s interview with Dr. Raul Uppot, we discuss key points of HCC from this year which IO professionals must recognize.
In this brief highlight from IO Learning’s interview with Dr. Raul Uppot, we discuss key points of HCC from this year which IO professionals must recognize.
In this brief highlight from IO...
10/26/2023
IO Learning
Dr. Ripal Gandhi HCC
Interview
Locoregional Therapies and High Lung Shunts: An HCC Highlight With Dr. Ripal Gandhi
10/25/2023
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM,...
10/25/2023
IO Learning
Dr. Keith Chan, MD
Videos
Liver Cancer Awareness Month: Addressing AAPI Disparities With Dr. Keith Chan
10/25/2023
In this interview during Liver Cancer Awareness Month, we discuss with Dr. Keith Chan the need for hepatocellular carcinoma (HCC) liver cancer awareness.
In this interview during Liver Cancer Awareness Month, we discuss with Dr. Keith Chan the need for hepatocellular carcinoma (HCC) liver cancer awareness.
In this interview during Liver...
10/25/2023
IO Learning

SIO Session at CIO 2021: NCCN Guidelines

Where Does IO Stand in the NCCN Guidelines: Panel Discussion
02/16/2022
Where Does IO Stand in the NCCN Guidelines: Renal Cell Carcinoma
02/16/2022
Where Does IO Stand in the NCCN Guidelines: Lung and Metastases to the Lung
02/16/2022
Where Does IO Stand in the NCCN Guidelines: mNET and Other Tumor Types
02/16/2022
Where Does IO Stand in the NCCN Guidelines: mCRC
02/16/2022
Where Does IO Stand in the NCCN Guidelines: ICC
02/16/2022
Where Does IO Stand in the NCCN Guidelines: HCC
02/16/2022
Dr. David S. Wang
CIO Presentation
HCC: Year in Review With Dr. David S. Wang
11/09/2023
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang,...
11/09/2023
IO Learning
Callstrom CIO
Musculoskeletal Oncologic Interventions: 2022 Year in Review
Matthew Callstrom, MD, PhD presents notable 2022 studies on musculoskeletal interventions at the Symposium on Clinical Interventional Oncology.
01/06/2023
Ahmed CIO Video
Renal Ablation: 2022 Year in Review
Muneeb Ahmed, MD, FSIR presents notable 2022 studies on renal ablation at the Symposium on Clinical Interventional Oncology.
01/06/2023
Robert Suh
Lung Ablation: 2022 Year in Review
Robert Suh, MD presents notable 2022 studies on lung ablation at the Symposium on Clinical Interventional Oncology.
01/06/2023
Ganguli CIO
Y90 Update on Metastatic Disease: 2022 Year in Review
Suvranu Ganguli, MD, FSIR presents notable 2022 studies on Y-90 for metastatic disease at the Symposium on Clinical Interventional Oncology.
01/06/2023
Tabori CIO
Y90: 2022 Year in Review
Nora Tabori, MD presents notable Y-90 studies at the Symposium on Clinical Interventional Oncology in 2022.
01/06/2023
Dan Brown
Liver Metastatic Disease: 2022 Year in Review
Daniel Brown, MD, FSIR reviews noteworthy 2022 studies on liver metastatic disease at the Symposium on Clinical Interventional Oncology.
01/04/2023
Riad Salem, MD, MBA
HCC: 2022 Year in Review
Riad Salem, MD, MBA presents notable studies from 2022 at the Symposium on Clinical Interventional Oncology.
01/01/2023
Dr Abdel Aal
HCC Treatment Complicated by Pneumothorax
02/17/2022
Dr Prologo
Cement Placement Complicated by Extra Vertebral Body
02/17/2022

Subscribe

IO Learning Newsletter

News

SIO Talk Tuesdays with Rony Avritscher, MD, moderated by Brad Wood, MD, and Haley Leopold, MD RMSS Co-Moderator
News
Attend the First SIO Talk Tuesdays Event
06/06/2023
Washington, DC (6 June 2023) — Join SIO next Tuesday for the first Talk Tuesdays of the summer! The free virtual series of ducational lectures is designed to help you advance your career in interventional radiology. The series kicks off on...
Washington, DC (6 June 2023) — Join SIO next Tuesday for the first Talk Tuesdays of the summer! The free virtual series of ducational lectures is designed to help you advance your career in interventional radiology. The series kicks off on...
Washington, DC (6 June 2023) —...
06/06/2023
IO Learning
News
Society of Interventional Oncology Announces First Site Approved for Enrollment in ACCLAIM Clinical Trial
01/13/2023
Washington, DC (13 January 2023) – The Society of Interventional Oncology (SIO) proudly announces Mayo Clinic as the first site approved and activated for enrollment on the society’s primary clinical trial, “Ablation with...
Washington, DC (13 January 2023) – The Society of Interventional Oncology (SIO) proudly announces Mayo Clinic as the first site approved and activated for enrollment on the society’s primary clinical trial, “Ablation with...
Washington, DC (13 January 2023)...
01/13/2023
IO Learning
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Radiation Therapy May Be Potential Heart Failure Treatment
11/28/2023
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose...
11/28/2023
Cath Lab Digest
News
Canon Medical Introduces Alphenix Sky 12 HD Interventional System
09/12/2023
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) —...
09/12/2023
IO Learning
News
A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
09/11/2023
New York, NY (11 September 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the details of an oral...
New York, NY (11 September 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the details of an oral...
New York, NY (11 September 2023)...
09/11/2023
IO Learning
News
Boston Scientific Receives 510(k) Clearance for Expanded Cryoablation System
08/25/2023
Marlborough, MA. (25 August 2023) — Boston Scientific has received 510(k) clearance for expanded indication of the VISUAL ICE cryoablation system. The clearance grants this device an indication expansion to now...
Marlborough, MA. (25 August 2023) — Boston Scientific has received 510(k) clearance for expanded indication of the VISUAL ICE cryoablation system. The clearance grants this device an indication expansion to now...
Marlborough, MA. (25 August...
08/25/2023
IO Learning
News
Delcath Systems Announces FDA Approval of HEPZATO KIT for the Treatment of Adult Patients With Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
08/21/2023
New York, NY. (21 August 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that today the US Food and Drug...
New York, NY. (21 August 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that today the US Food and Drug...
New York, NY. (21 August 2023)...
08/21/2023
IO Learning
News
HMP Global Earns Healthcare Industry Top Workplaces Award for Company Culture, Employee Satisfaction
08/18/2023
Malvern, PA (18 August 2023) — HMP Global, the leading omnichannel events and education company, is one of only 111 companies nationwide to earn a 2023 Healthcare Industry Top Workplaces award, its fifth award this year based on employee...
Malvern, PA (18 August 2023) — HMP Global, the leading omnichannel events and education company, is one of only 111 companies nationwide to earn a 2023 Healthcare Industry Top Workplaces award, its fifth award this year based on employee...
Malvern, PA (18 August 2023)...
08/18/2023
IO Learning
News
Siemens Healthineers Announces Partnership With SSM Health
08/14/2023
Erlangen, Germany (14 August 2023) —SSM Health and Siemens Healthineers have announced a new 10-year strategic partnership agreement focused on expanding access to high-quality care and training the next generation of health care...
Erlangen, Germany (14 August 2023) —SSM Health and Siemens Healthineers have announced a new 10-year strategic partnership agreement focused on expanding access to high-quality care and training the next generation of health care...
Erlangen, Germany (14 August...
08/14/2023
IO Learning
News
Interventional Oncology Accreditation Program IASIOS Continues to Reach new Heights
08/11/2023
Vienna, Austria (11 August 2023) — The only accreditation system of its kind has nearly tripled its network of esteemed interventional oncology centers worldwide since launching in 2021.The International Accreditation System...
Vienna, Austria (11 August 2023) — The only accreditation system of its kind has nearly tripled its network of esteemed interventional oncology centers worldwide since launching in 2021.The International Accreditation System...
Vienna, Austria (11 August 2023)...
08/11/2023
IO Learning
News
Accuray Receives FDA 510(k) Clearance for its VitalHold™ on the Radixact® System
08/10/2023
Madison, WI (10 August 2023) — Accuray Incorporated has announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VitalHold™* breast package on...
Madison, WI (10 August 2023) — Accuray Incorporated has announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VitalHold™* breast package on...
Madison, WI (10 August 2023)...
08/10/2023
IO Learning

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use